A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation

Brittany B. DeBerry, James E. Lynch, Jill M. Chernin, Joseph B. Zwischenberger, Dai H. Chung

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Routine administration of large amounts of pain and sedative medication is common to critically ill pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) for cardiopulmonary failure. It has been our experience that pediatric patients are the most difficult age group in which to achieve an ideal pain and sedative control due to the narrow margin of safety. The purpose of this study was to determine the general practice guideline used for pain and anxiolytic pharmacotherapy for pediatric patients at ECMO centers. We sent a survey questionnaire to all ECMO centers in the USA that treat pediatric respiratory failure patients. Of the 46 responding centers (including telephone follow-ups), 37 (80%) centers had an active pediatric ECMO programs for patients with severe respiratory failure. Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred. Subjective effectiveness of various pharmacological agents was variable without clear consensus; however, midazolam was considered to be the most effective agent used.

Original languageEnglish (US)
Pages (from-to)139-143
Number of pages5
JournalPerfusion
Volume20
Issue number3
DOIs
StatePublished - Jul 25 2005
Externally publishedYes

Fingerprint

Extracorporeal Membrane Oxygenation
Pediatrics
Oxygenation
pain
medication
Membranes
Pain
Hypnotics and Sedatives
Respiratory Insufficiency
Drug therapy
telephone
age group
Telephone
Midazolam
Anti-Anxiety Agents
Fentanyl
Practice Guidelines
Critical Illness
General Practice
Surveys and Questionnaires

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Safety Research
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation. / DeBerry, Brittany B.; Lynch, James E.; Chernin, Jill M.; Zwischenberger, Joseph B.; Chung, Dai H.

In: Perfusion, Vol. 20, No. 3, 25.07.2005, p. 139-143.

Research output: Contribution to journalArticle

DeBerry, Brittany B. ; Lynch, James E. ; Chernin, Jill M. ; Zwischenberger, Joseph B. ; Chung, Dai H. / A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation. In: Perfusion. 2005 ; Vol. 20, No. 3. pp. 139-143.
@article{01d1a6c80ee048ee9f52de9c2617646e,
title = "A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation",
abstract = "Routine administration of large amounts of pain and sedative medication is common to critically ill pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) for cardiopulmonary failure. It has been our experience that pediatric patients are the most difficult age group in which to achieve an ideal pain and sedative control due to the narrow margin of safety. The purpose of this study was to determine the general practice guideline used for pain and anxiolytic pharmacotherapy for pediatric patients at ECMO centers. We sent a survey questionnaire to all ECMO centers in the USA that treat pediatric respiratory failure patients. Of the 46 responding centers (including telephone follow-ups), 37 (80{\%}) centers had an active pediatric ECMO programs for patients with severe respiratory failure. Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred. Subjective effectiveness of various pharmacological agents was variable without clear consensus; however, midazolam was considered to be the most effective agent used.",
author = "DeBerry, {Brittany B.} and Lynch, {James E.} and Chernin, {Jill M.} and Zwischenberger, {Joseph B.} and Chung, {Dai H.}",
year = "2005",
month = "7",
day = "25",
doi = "10.1191/0267659105pf801oa",
language = "English (US)",
volume = "20",
pages = "139--143",
journal = "Perfusion (United Kingdom)",
issn = "0267-6591",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - A survey for pain and sedation medications in pediatric patients during extracorporeal membrane oxygenation

AU - DeBerry, Brittany B.

AU - Lynch, James E.

AU - Chernin, Jill M.

AU - Zwischenberger, Joseph B.

AU - Chung, Dai H.

PY - 2005/7/25

Y1 - 2005/7/25

N2 - Routine administration of large amounts of pain and sedative medication is common to critically ill pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) for cardiopulmonary failure. It has been our experience that pediatric patients are the most difficult age group in which to achieve an ideal pain and sedative control due to the narrow margin of safety. The purpose of this study was to determine the general practice guideline used for pain and anxiolytic pharmacotherapy for pediatric patients at ECMO centers. We sent a survey questionnaire to all ECMO centers in the USA that treat pediatric respiratory failure patients. Of the 46 responding centers (including telephone follow-ups), 37 (80%) centers had an active pediatric ECMO programs for patients with severe respiratory failure. Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred. Subjective effectiveness of various pharmacological agents was variable without clear consensus; however, midazolam was considered to be the most effective agent used.

AB - Routine administration of large amounts of pain and sedative medication is common to critically ill pediatric patients undergoing extracorporeal membrane oxygenation (ECMO) for cardiopulmonary failure. It has been our experience that pediatric patients are the most difficult age group in which to achieve an ideal pain and sedative control due to the narrow margin of safety. The purpose of this study was to determine the general practice guideline used for pain and anxiolytic pharmacotherapy for pediatric patients at ECMO centers. We sent a survey questionnaire to all ECMO centers in the USA that treat pediatric respiratory failure patients. Of the 46 responding centers (including telephone follow-ups), 37 (80%) centers had an active pediatric ECMO programs for patients with severe respiratory failure. Fentanyl was the most commonly used pain medication and continuous infusion, administered directly to the patient, was preferred. Subjective effectiveness of various pharmacological agents was variable without clear consensus; however, midazolam was considered to be the most effective agent used.

UR - http://www.scopus.com/inward/record.url?scp=22144484112&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22144484112&partnerID=8YFLogxK

U2 - 10.1191/0267659105pf801oa

DO - 10.1191/0267659105pf801oa

M3 - Article

C2 - 16038385

AN - SCOPUS:22144484112

VL - 20

SP - 139

EP - 143

JO - Perfusion (United Kingdom)

JF - Perfusion (United Kingdom)

SN - 0267-6591

IS - 3

ER -